Profile data is unavailable for this security.
About the company
China Resources Pharmaceutical Group Ltd is an investment holding company principally engaged in the pharmaceutical business. The Company operates its business through four segments. The Pharmaceutical Business segment develops, manufactures and sells a range of pharmaceuticals and health products. The Pharmaceutical Distribution Business segment provides distribution, warehousing, logistics and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers, device manufacturer and dispensers, including hospitals, distributors and retail pharmacies. The Pharmaceutical Retail Business segment operates retail pharmacies. The Other Business Operations segment engages in property holding and other businesses.
- Revenue in HKD (TTM)295.21bn
- Net income in HKD3.19bn
- Incorporated2007
- Employees86.00k
- LocationChina Resources Pharmaceutical Group LtdRoom 4104-05, 41F,China Resources BuldngNo. 26, Harbour Road, Wan Chai Hong KongHKG
- Phone+852 25938991
- Fax+852 25938992
- Websitehttps://www.crpharm.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vigonvita Life Sciences Co Ltd | -100.00bn | -100.00bn | 20.11bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -94.07 | -- | -1,848.73 | -- | -- | -- |
| HUTCHMED (China) Ltd | 4.71bn | 3.65bn | 20.31bn | 1.78k | 5.57 | 2.11 | 5.42 | 4.32 | 4.18 | 4.18 | 5.39 | 11.01 | 0.3966 | 7.09 | 3.86 | 2,598,691.00 | 30.79 | -9.55 | 40.72 | -13.77 | 44.15 | 39.84 | 77.64 | -20.32 | 4.51 | -- | 0.07 | -- | -24.80 | 25.20 | -62.56 | -- | 15.93 | -- |
| Ab&B Bio Tech Co Ltd JS | 366.27m | -253.90m | 22.39bn | 583.00 | -- | 587.93 | -- | 61.12 | -0.6453 | -0.6453 | 0.9309 | 0.0968 | -- | -- | -- | -- | -- | -- | -- | -- | 67.29 | -- | -69.32 | -- | 0.3162 | -9.49 | 0.9646 | -- | 397.65 | -- | 39.09 | -- | -- | -- |
| Shanghai Henlius Biotech Inc | 6.56bn | 932.54m | 24.40bn | 3.54k | 41.09 | 9.94 | 17.29 | 3.72 | 1.72 | 1.72 | 12.07 | 7.09 | 0.5386 | 1.73 | 5.86 | 1,866,062.00 | 7.66 | -3.21 | 13.85 | -5.76 | 75.77 | 72.50 | 14.22 | -7.87 | 0.5046 | 10.47 | 0.5185 | -- | 6.11 | 128.98 | 50.26 | -- | 10.83 | -- |
| The United Laboratories Intl. Hldgs Ltd. | 15.95bn | 3.46bn | 24.84bn | 17.40k | 6.60 | 1.30 | 5.96 | 1.56 | 1.91 | 1.91 | 8.78 | 9.69 | 0.5397 | 2.89 | 5.97 | 938,443.90 | 11.71 | 9.37 | 17.46 | 14.54 | 47.24 | 44.33 | 21.70 | 15.06 | 1.60 | -- | 0.2472 | 26.01 | 0.1387 | 10.39 | -1.54 | 32.89 | 37.25 | 45.96 |
| Sunshine Lake Pharma Co Ltd | 3.82bn | -447.94m | 25.20bn | 6.53k | -- | 56.99 | 21,090.14 | 6.60 | -0.7768 | -0.7768 | 6.62 | 0.7674 | -- | -- | -- | 582,865.20 | -- | -- | -- | -- | 73.62 | -- | -12.86 | -- | 0.7739 | -0.7591 | 0.5111 | -- | -37.06 | -- | -212.17 | -- | -- | -- |
| PegBio Co Ltd | -100.00bn | -100.00bn | 26.05bn | 58.00 | -- | 89.02 | -- | -- | -- | -- | -- | 0.7481 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.07 | -- | 0.2439 | -- | -- | -- | -1.49 | -- | -- | -- |
| Grand Pharmaceutical Group Ltd | 11.70bn | 2.08bn | 26.80bn | 12.44k | 12.70 | 1.54 | 10.34 | 2.29 | 0.5943 | 0.5943 | 3.35 | 4.90 | 0.4557 | 3.66 | 3.88 | 976,472.80 | 7.99 | 10.40 | 10.81 | 14.24 | 57.64 | 61.04 | 17.53 | 22.80 | 0.9872 | -- | 0.2107 | 29.12 | 10.59 | 12.06 | 31.30 | 16.49 | 0.7398 | 22.05 |
| China Resources Pharmaceutical Group Ltd | 295.21bn | 3.19bn | 28.84bn | 86.00k | 9.03 | 0.5101 | 2.21 | 0.0977 | 0.5084 | 0.5084 | 46.99 | 9.00 | 0.9434 | 5.57 | 2.41 | 4,060,622.00 | 2.86 | 3.14 | 10.28 | 11.78 | 15.81 | 15.59 | 3.03 | 3.02 | 1.12 | 11.26 | 0.4248 | 22.38 | 5.30 | 7.41 | -13.06 | 2.95 | 12.42 | 7.30 |
| Duality Biotherapeutics Inc | 2.46bn | -3.20bn | 30.92bn | 191.00 | -- | 9.16 | -- | 12.59 | -36.95 | -36.95 | 28.68 | 37.43 | -- | -- | -- | 14,443,290.00 | -- | -- | -- | -- | 37.13 | -- | -130.43 | -- | -- | -- | 0.0228 | -- | 8.66 | -- | -193.82 | -- | -- | -- |
| Simcere Pharmaceutical Group Ltd | 8.04bn | 995.75m | 32.71bn | 6.82k | 31.13 | 3.81 | 23.46 | 4.07 | 0.4048 | 0.4048 | 3.26 | 3.31 | 0.5845 | 2.20 | 2.81 | 1,221,108.00 | 7.24 | 8.74 | 9.93 | 12.42 | 81.00 | 78.53 | 12.39 | 15.60 | 1.57 | 4.72 | 0.1453 | 44.12 | 0.4148 | 5.67 | 2.57 | -6.09 | 8.48 | -- |
| Xuanzhu Biopharmaceutical Co Ltd | 36.15m | -629.42m | 33.07bn | 197.00 | -- | 34.56 | -- | 914.74 | -1.22 | -1.22 | 0.0698 | 1.85 | -- | -- | -- | -- | -- | -- | -- | -- | 41.02 | -- | -1,740.97 | -- | 1.10 | -- | 0.0013 | -- | 103,672.40 | -- | -85.13 | -- | -- | -- |
| China Medical System Holdings Ltd | 8.89bn | 1.87bn | 37.40bn | 6.10k | 19.85 | 1.94 | 17.33 | 4.21 | 0.7724 | 0.7724 | 3.68 | 7.89 | 0.4239 | 3.14 | 6.12 | 1,447,972.00 | 8.85 | 16.35 | 9.88 | 18.70 | 71.47 | 75.03 | 20.88 | 32.20 | 5.28 | -- | 0.0417 | 40.16 | -6.79 | 4.22 | -32.54 | -3.75 | 6.01 | -2.60 |
Data as of Feb 16 2026. Currency figures normalised to China Resources Pharmaceutical Group Ltd's reporting currency: Hong Kong Dollar HKD
3.54%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 04 Feb 2026 | 72.13m | 1.15% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 41.57m | 0.66% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 26.61m | 0.42% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 23.07m | 0.37% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 14.49m | 0.23% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 10.26m | 0.16% |
| Geode Capital Management LLCas of 31 Dec 2025 | 9.79m | 0.16% |
| State Street Global Advisors Ltd.as of 05 Feb 2026 | 8.51m | 0.14% |
| BlackRock Advisors (UK) Ltd.as of 06 Feb 2026 | 8.04m | 0.13% |
| Causeway Capital Management LLCas of 31 Dec 2025 | 7.96m | 0.13% |
More ▼
Data from 30 Nov 2025 - 12 Feb 2026Source: FactSet Research Systems Inc.
